GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Xtant Medical Holdings Inc (FRA:XMS) » Definitions » Shiller PE Ratio

Xtant Medical Holdings (FRA:XMS) Shiller PE Ratio : (As of Jun. 10, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Xtant Medical Holdings Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Xtant Medical Holdings Shiller PE Ratio Historical Data

The historical data trend for Xtant Medical Holdings's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xtant Medical Holdings Shiller PE Ratio Chart

Xtant Medical Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Xtant Medical Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Xtant Medical Holdings's Shiller PE Ratio

For the Medical Devices subindustry, Xtant Medical Holdings's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Xtant Medical Holdings's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Xtant Medical Holdings's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Xtant Medical Holdings's Shiller PE Ratio falls into.



Xtant Medical Holdings Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Xtant Medical Holdings's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Xtant Medical Holdings's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.028/131.7762*131.7762
=-0.028

Current CPI (Mar. 2024) = 131.7762.

Xtant Medical Holdings Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 -2.811 100.560 -3.684
201409 -1.609 100.428 -2.111
201412 -4.337 99.070 -5.769
201503 -6.252 99.621 -8.270
201506 -3.987 100.684 -5.218
201509 -6.224 100.392 -8.170
201512 9.718 99.792 12.833
201603 -5.025 100.470 -6.591
201606 -3.921 101.688 -5.081
201609 -4.243 101.861 -5.489
201612 -3.499 101.863 -4.527
201703 -3.590 102.862 -4.599
201706 -5.681 103.349 -7.244
201709 -4.681 104.136 -5.923
201712 -15.787 104.011 -20.001
201803 -0.564 105.290 -0.706
201806 -0.323 106.317 -0.400
201809 -0.204 106.507 -0.252
201812 -3.761 105.998 -4.676
201903 -0.184 107.251 -0.226
201906 -0.132 108.070 -0.161
201909 -0.126 108.329 -0.153
201912 -0.116 108.420 -0.141
202003 -0.172 108.902 -0.208
202006 -0.169 108.767 -0.205
202009 -0.085 109.815 -0.102
202012 -0.008 109.897 -0.010
202103 0.000 111.754 0.000
202106 -0.008 114.631 -0.009
202109 -0.017 115.734 -0.019
202112 -0.027 117.630 -0.030
202203 -0.027 121.301 -0.029
202206 -0.019 125.017 -0.020
202209 -0.030 125.227 -0.032
202212 -0.019 125.222 -0.020
202303 -0.019 127.348 -0.020
202306 -0.018 128.729 -0.018
202309 0.066 129.860 0.067
202312 -0.028 129.419 -0.029
202403 -0.028 131.776 -0.028

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Xtant Medical Holdings  (FRA:XMS) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Xtant Medical Holdings Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Xtant Medical Holdings's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Xtant Medical Holdings (FRA:XMS) Business Description

Traded in Other Exchanges
Address
664 Cruiser Lane, Belgrade, MT, USA, 59714
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.

Xtant Medical Holdings (FRA:XMS) Headlines

No Headlines